Javascript must be enabled to continue!
Polymersomes as Innovative, Stimuli-Responsive Platforms for Cancer Therapy
View through CrossRef
This review addresses the urgent need for more targeted and less toxic cancer treatments by exploring the potential of multi-responsive polymersomes. These advanced nanocarriers are engineered to deliver drugs precisely to tumor sites by responding to specific stimuli such as pH, temperature, light, hypoxia, and redox conditions, thereby minimizing the side effects associated with traditional chemotherapy. We discuss the design, synthesis, and recent applications of polymersomes, emphasizing their ability to improve therapeutic outcomes through controlled drug release and targeted delivery. Moreover, we highlight the critical areas for future research, including the optimization of polymersome–biological interactions and biocompatibility, to facilitate their clinical adoption. Multi-responsive polymersomes emerge as a promising development in nanomedicine, offering a pathway to safer and more effective cancer treatments.
Title: Polymersomes as Innovative, Stimuli-Responsive Platforms for Cancer Therapy
Description:
This review addresses the urgent need for more targeted and less toxic cancer treatments by exploring the potential of multi-responsive polymersomes.
These advanced nanocarriers are engineered to deliver drugs precisely to tumor sites by responding to specific stimuli such as pH, temperature, light, hypoxia, and redox conditions, thereby minimizing the side effects associated with traditional chemotherapy.
We discuss the design, synthesis, and recent applications of polymersomes, emphasizing their ability to improve therapeutic outcomes through controlled drug release and targeted delivery.
Moreover, we highlight the critical areas for future research, including the optimization of polymersome–biological interactions and biocompatibility, to facilitate their clinical adoption.
Multi-responsive polymersomes emerge as a promising development in nanomedicine, offering a pathway to safer and more effective cancer treatments.
Related Results
Biodegradable and dual-targeting polymersomes for sitespecific drug delivery against Parkinson’s Disease
Biodegradable and dual-targeting polymersomes for sitespecific drug delivery against Parkinson’s Disease
Polymersomes biodégradables à double ciblage pour l'administration ciblée de médicaments contre la maladie de Parkinson
Les troubles cérébraux représentent l’un des...
Stimuli-responsive polymersomes : Thermosensitivity and biodegradability
Stimuli-responsive polymersomes : Thermosensitivity and biodegradability
Polymersomes stimulables : Thermosensibilité et biodégradabilité
Les polymersomes sont des vésicules dont la membrane est formée d'une bicouche de polymères amphiph...
International Breast Cancer Study Group (IBCSG)
International Breast Cancer Study Group (IBCSG)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by International Breast Cancer Study Group (IBCSG). Clinical tria...
Targeted Polymersomes Enable Enhanced Delivery to Peripheral Nerves Post-Injury
Targeted Polymersomes Enable Enhanced Delivery to Peripheral Nerves Post-Injury
Abstract
The gold standard therapy for peripheral nerve injuries involves surgical repair, which is invasive and leads to major variations in therapeutic outcomes. ...
Co-delivery of anti-inflammatory and antioxidant agents via polymersomes for osteoarthritis therapy
Co-delivery of anti-inflammatory and antioxidant agents via polymersomes for osteoarthritis therapy
BackgroundOsteoarthritis (OA) is a chronic degenerative joint disease primarily driven by inflammation and oxidative stress. This study aimed to develop a polymersome-based co-deli...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

